Zettl UK - Search Results

1

Current Pharmaceutical Trends in Neuroimmunology - Part I: Disorders Affecting the CNS.

Rommer PS, Zettl UK. Rommer PS, et al. Among authors: zettl uk. Curr Pharm Des. 2022;28(6):427. doi: 10.2174/138161282806220218141218. Curr Pharm Des. 2022. PMID: 35379121 No abstract available.

2

A woman with acute myelopathy in pregnancy: case outcome.

Reuss R, Rommer PS, Brück W, Paul F, Bolz M, Jarius S, Boettcher T, Grossmann A, Bock A, Zipp F, Benecke R, Zettl UK. Reuss R, et al. Among authors: zettl uk. BMJ. 2009 Dec 10;339:b4026. doi: 10.1136/bmj.b4026. BMJ. 2009. PMID: 20007656 No abstract available.

3

Rituximab for secondary progressive multiple sclerosis: a case series.

Rommer PS, Patejdl R, Winkelmann A, Benecke R, Zettl UK. Rommer PS, et al. Among authors: zettl uk. CNS Drugs. 2011 Jul;25(7):607-13. doi: 10.2165/11589390-000000000-00000. CNS Drugs. 2011. PMID: 21699272

4

Longitudinal extensive transverse myelitis--it's not all neuromyelitis optica.

Trebst C, Raab P, Voss EV, Rommer P, Abu-Mugheisib M, Zettl UK, Stangel M. Trebst C, et al. Among authors: zettl uk. Nat Rev Neurol. 2011 Nov 1;7(12):688-98. doi: 10.1038/nrneurol.2011.176. Nat Rev Neurol. 2011. PMID: 22045269 Review.

5

Failure of natalizumab to prevent relapses in neuromyelitis optica.

Kleiter I, Hellwig K, Berthele A, Kümpfel T, Linker RA, Hartung HP, Paul F, Aktas O; Neuromyelitis Optica Study Group. Kleiter I, et al. Arch Neurol. 2012 Feb;69(2):239-45. doi: 10.1001/archneurol.2011.216. Arch Neurol. 2012. PMID: 22332191

6

Monoclonal antibodies in the treatment of neuroimmunological diseases.

Rommer PS, Patejdl R, Zettl UK. Rommer PS, et al. Among authors: zettl uk. Curr Pharm Des. 2012;18(29):4498-507. doi: 10.2174/138161212802502125. Curr Pharm Des. 2012. PMID: 22612751 Review.

7

Effect of methylprednisolone on mammalian neuronal networks in vitro.

Wittstock M, Rommer PS, Schiffmann F, Jügelt K, Stüwe S, Benecke R, Schiffmann D, Zettl UK. Wittstock M, et al. Among authors: zettl uk. Cell Mol Neurobiol. 2015 Jan;35(1):111-4. doi: 10.1007/s10571-014-0117-y. Epub 2014 Oct 5. Cell Mol Neurobiol. 2015. PMID: 25283186

8

Patients characteristics influencing the longitudinal utilization of steroids in multiple sclerosis--an observational study.

Rommer PS, Buckow K, Ellenberger D, Friede T, Pitschnau-Michel D, Fuge J, Stüve O, Zettl UK; German Multiple Sclerosis Registry of the German National MS Society. Rommer PS, et al. Among authors: zettl uk. Eur J Clin Invest. 2015 Jun;45(6):587-93. doi: 10.1111/eci.12450. Epub 2015 May 9. Eur J Clin Invest. 2015. PMID: 25868705

9

Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses.

Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Wegner B, Hellwig K, Pache F, Ruprecht K, Havla J, Krumbholz M, Kümpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Stellmann JP, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker R, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Winkelmann A, Marouf W, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C; Neuromyelitis Optica Study Group. Kleiter I, et al. Ann Neurol. 2016 Feb;79(2):206-16. doi: 10.1002/ana.24554. Epub 2015 Nov 26. Ann Neurol. 2016. PMID: 26537743

10

Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis.

Zettl UK, Rommer P, Hipp P, Patejdl R. Zettl UK, et al. Ther Adv Neurol Disord. 2016 Jan;9(1):9-30. doi: 10.1177/1756285615612659. Ther Adv Neurol Disord. 2016. PMID: 26788128 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

336 results

Search Page